Bunge Global SA's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Bunge Global SA reported revenue of $70.3B (+32.4% year on year) and net income of $843.0M (-29.0% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY |
|---|---|---|---|
| Net sales | $70.3B | $53.1B | $59.5B |
| Cost of goods sold | ($66.9B) | ($49.7B) | ($54.7B) |
| Gross profit | $3.4B | $3.4B | $4.8B |
| Selling, general and administrative expenses | ($2.1B) | ($1.8B) | ($1.7B) |
| Interest income | $202.0M | $163.0M | $148.0M |
| Interest expense | ($628.0M) | ($471.0M) | ($516.0M) |
| Foreign exchange (losses) gains — net | ($51.0M) | ($189.0M) | $20.0M |
| Other income — net | $289.0M | $442.0M | $129.0M |
| Income (loss) from affiliates | $26.0M | ($38.0M) | $140.0M |
| Income from continuing operations before income tax | $1.1B | $1.5B | $3.1B |
| Income tax expense | ($288.0M) | ($336.0M) | ($714.0M) |
| Income from continuing operations | $846.0M | — | — |
| Loss from discontinued operations, net of tax | ($3.0M) | — | — |
| Net income | $843.0M | $1.2B | $2.3B |
| Net income attributable to noncontrolling interests and redeemable noncontrolling interests | ($27.0M) | ($51.0M) | ($94.0M) |
| Net income attributable to Bunge shareholders (Note 23) | $816.0M | $1.1B | $2.2B |
| Net income from continuing operations (in dollars per share) | $4.97 | — | — |
| Net income attributable to Bunge shareholders—basic (in dollars per share) | $4.95 | $8.09 | $15.07 |
| Net income from continuing operations (in dollars per share) | $4.93 | — | — |
| Net loss from discontinued operations (in dollars per share) | -$0.02 | — | — |
| Net income attributable to Bunge shareholders —diluted (in dollars per share) | $4.91 | $7.99 | $14.87 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Net sales | $24.0B | $21.9B | $22.2B | $12.8B |
| Cost of goods sold | ($22.4B) | ($21.1B) | ($21.1B) | ($12.0B) |
| Gross profit | $1.7B | $766.0M | $1.1B | $738.0M |
| Selling, general and administrative expenses | ($606.0M) | ($531.0M) | ($678.0M) | ($418.0M) |
| Interest income | $43.0M | $45.0M | $57.0M | $46.0M |
| Interest expense | ($197.0M) | ($181.0M) | ($202.0M) | ($106.0M) |
| Foreign exchange gains (losses) – net | ($26.0M) | ($94.0M) | ($55.0M) | $44.0M |
| Other income (expense) – net | $39.0M | $53.0M | $77.0M | $187.0M |
| Income (loss) from affiliates | $9.0M | $3.0M | $8.0M | $3.0M |
| Income (loss) before income tax | $943.0M | $61.0M | $270.0M | $494.0M |
| Income tax (expense) benefit | ($236.0M) | $14.0M | ($86.0M) | ($124.0M) |
| Net income (loss) | $707.0M | $75.0M | $181.0M | $370.0M |
| Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests | ($29.0M) | ($7.0M) | ($15.0M) | ($16.0M) |
| Net income (loss) attributable to Bunge shareholders (Note 18) | $678.0M | $68.0M | $166.0M | $354.0M |
| Net income (loss) attributable to Bunge shareholders - basic (in dollars per share) | $3.50 | $0.35 | $0.84 | $2.63 |
| Net income (loss) attributable to Bunge shareholders - diluted (in dollars per share) | $3.47 | $0.35 | $0.84 | $2.61 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY |
|---|---|---|---|
| Cash and cash equivalents | $1.1B | $3.3B | $2.6B |
| Time deposits under trade structured finance program (Note 3) | $208.0M | — | — |
| Trade accounts receivable (less allowances of $156 and $89) (Note 4) | $3.9B | $2.1B | $2.6B |
| Inventories (Note 5) | $13.2B | $6.5B | $7.1B |
| Assets held for sale (Note 2) | $191.0M | — | $1.0M |
| Other current assets (Note 6) | $5.8B | $4.0B | $4.0B |
| Total current assets | $24.4B | $16.0B | $16.4B |
| Property, plant and equipment, net (Note 7) | $11.7B | $5.3B | $4.5B |
| Operating lease assets (Note 25) | $1.7B | $932.0M | $926.0M |
| Goodwill | $3.1B | $453.0M | $489.0M |
| Other intangible assets, net (Note 9) | $309.0M | $321.0M | $398.0M |
| Investments in affiliates (Note 11) | $1.5B | $779.0M | $1.3B |
| Deferred income taxes (Note 14) | $890.0M | $645.0M | $773.0M |
| Other non-current assets (Note 12) | $938.0M | $557.0M | $615.0M |
| Total assets | $44.5B | $24.9B | $25.4B |
| Short-term debt (Note 17) | $3.9B | $875.0M | $797.0M |
| Current portion of long-term debt (Note 17) | $1.3B | $669.0M | $5.0M |
| Letter of credit obligations under trade structured finance program (Note 3) | $208.0M | — | — |
| Trade accounts payable (includes $559 and $388 carried at fair value) | $4.9B | $2.8B | $3.7B |
| Current operating lease obligations (Note 25) | $499.0M | $286.0M | $308.0M |
| Liabilities held for sale (Note 2) | $61.0M | — | $0 |
| Other current liabilities (Note 13) | $4.3B | $2.8B | $2.9B |
| Total current liabilities | $15.1B | $7.4B | $7.7B |
| Long-term debt (Note 17) | $8.8B | $4.7B | $4.1B |
| Deferred income taxes (Note 14) | $988.0M | $379.0M | $400.0M |
| Non-current operating lease obligations (Note 25) | $1.1B | $595.0M | $566.0M |
| Other non-current liabilities (Note 21) | $1.1B | $847.0M | $824.0M |
| Redeemable noncontrolling interests | $53.0M | $4.0M | $1.0M |
| Registered shares, par value $0.01; authorized not issued—33,632,445 shares; conditionally authorized 32,285,894 shares; issued and outstanding: 2025 - 193,408,656 shares, 2024 - 133,964,235 shares | 2.0M | 1.0M | 1.0M |
| Additional paid-in capital | $9.8B | $5.3B | $5.9B |
| Retained earnings | $13.2B | $12.8B | $12.1B |
| Accumulated other comprehensive loss (Note 22) | ($6.1B) | ($6.7B) | ($6.1B) |
| Treasury shares, at cost; 2025—15,103,107 shares and 2024—21,318,307 shares | -1.0B | — | — |
| Total Bunge shareholders' equity | $15.9B | $9.9B | $10.9B |
| Noncontrolling interests | $1.5B | $1.0B | $963.0M |
| Total equity | $17.4B | $10.9B | $11.8B |
| Total liabilities, redeemable noncontrolling interest and equity | $44.5B | $24.9B | $25.4B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $593.0M | $839.0M | $1.3B | $6.8B |
| Time deposits under trade structured finance program (Note 3) | $45.0M | $102.0M | $546.0M | — |
| Trade accounts receivable (net of allowances of $161 and $156) (Note 4) | $3.9B | $4.0B | $3.5B | $2.3B |
| Inventories (Note 5) | $15.5B | $15.4B | $13.3B | $8.0B |
| Assets held for sale (Note 2) | $312.0M | $196.0M | $194.0M | $178.0M |
| Other current assets (Note 6) | $5.9B | $6.6B | $7.9B | $4.2B |
| Total current assets | $26.2B | $27.1B | $26.7B | $21.4B |
| Property, plant and equipment, net | $11.9B | $11.9B | $11.6B | $5.8B |
| Operating lease assets | $1.7B | $1.7B | $1.7B | $1.0B |
| Goodwill | $3.4B | $3.3B | $2.8B | $460.0M |
| Other intangible assets, net | $288.0M | $304.0M | $328.0M | $316.0M |
| Investments in affiliates | $1.3B | $1.3B | $1.5B | $862.0M |
| Deferred income taxes | $902.0M | $934.0M | $789.0M | $646.0M |
| Other non-current assets (Note 7) | $1.1B | $1.1B | $906.0M | $595.0M |
| Total assets | $46.8B | $47.6B | $46.3B | $31.2B |
| Short-term debt (Note 13) | $4.6B | $3.2B | $4.4B | $3.5B |
| Current portion of long-term debt (Note 13) | $1.2B | $1.4B | $1.3B | $690.0M |
| Letter of credit obligations under trade structured finance program (Note 3) | $45.0M | $102.0M | $546.0M | — |
| Trade accounts payable (includes $874 and $559 carried at fair value) (Note 11) | $5.4B | $6.2B | $4.8B | $2.9B |
| Current operating lease obligations | $502.0M | $501.0M | $491.0M | $282.0M |
| Liabilities held for sale (Note 2) | $87.0M | $60.0M | $73.0M | $67.0M |
| Other current liabilities (Note 10) | $4.9B | $5.5B | $4.4B | $2.9B |
| Total current liabilities | $16.7B | $16.9B | $16.1B | $10.4B |
| Long-term debt (Note 13) | $9.4B | $9.9B | $9.8B | $7.0B |
| Deferred income taxes | $931.0M | $929.0M | $925.0M | $347.0M |
| Non-current operating lease obligations | $1.1B | $1.1B | $1.2B | $662.0M |
| Other non-current liabilities (Note 16) | $1.2B | $1.1B | $1.0B | $761.0M |
| Redeemable noncontrolling interest | $68.0M | $51.0M | $61.0M | $61.0M |
| Registered shares, par value $0.01; authorized not issued – 33,632,445 shares; conditionally authorized 32,285,894 shares; issued and outstanding: 2026 – 192,106,786 shares, 2025 – 193,408,656 shares | 2.0M | 2.0M | 2.0M | 1.0M |
| Additional paid-in capital | $9.8B | $9.8B | $10.9B | $5.5B |
| Retained earnings | $13.3B | $13.2B | $13.1B | $13.0B |
| Accumulated other comprehensive income (loss) (Note 17) | ($6.0B) | ($6.0B) | ($6.1B) | ($6.1B) |
| Treasury shares, at cost; 2026 - 16,404,977 shares and 2025 - 15,103,107 shares | -1.2B | -967.0M | -2.1B | -1.5B |
| Total Bunge shareholders’ equity | $16.0B | $16.0B | $15.8B | $10.9B |
| Noncontrolling interests | $1.4B | $1.4B | $1.5B | $1.0B |
| Total equity | $17.3B | $17.4B | $17.2B | $11.9B |
| Total liabilities, redeemable noncontrolling interest and equity | $46.8B | $47.6B | $46.3B | $31.2B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY |
|---|---|---|---|
| Net income | $843.0M | $1.2B | $2.3B |
| Impairment charges | $53.0M | $41.0M | $104.0M |
| Foreign exchange (gain) loss on debt | ($216.0M) | $174.0M | ($281.0M) |
| Depreciation, depletion and amortization | $703.0M | $468.0M | $451.0M |
| Share-based compensation expense | $73.0M | $65.0M | $69.0M |
| Deferred income tax benefit | ($62.0M) | ($10.0M) | ($1.0M) |
| Gain on sale of investments and property, plant and equipment | ($160.0M) | ($205.0M) | ($4.0M) |
| Results from affiliates | ($26.0M) | $19.0M | ($157.0M) |
| Other, net | $138.0M | $65.0M | $117.0M |
| Trade accounts receivable | ($469.0M) | $169.0M | $256.0M |
| Inventories | ($700.0M) | $96.0M | $1.5B |
| Secured advances to suppliers | $22.0M | $207.0M | ($121.0M) |
| Trade accounts payable and accrued liabilities | $153.0M | ($538.0M) | ($939.0M) |
| Advances on sales | ($58.0M) | $51.0M | ($140.0M) |
| Net unrealized (gains) losses on derivative contracts | $395.0M | $262.0M | ($366.0M) |
| Margin deposits | ($79.0M) | $36.0M | $173.0M |
| Recoverable and income taxes, net | ($11.0M) | ($242.0M) | $202.0M |
| Marketable securities | $15.0M | ($36.0M) | $23.0M |
| Other, net | $230.0M | $90.0M | $67.0M |
| Cash provided by operating activities | $844.0M | $1.9B | $3.3B |
| Payments made for capital expenditures | ($1.7B) | ($1.4B) | ($1.1B) |
| Acquisitions of businesses (net of cash acquired) | ($4.2B) | — | — |
| Proceeds from investments | $2.8B | $887.0M | $49.0M |
| Payments for investments | ($3.0B) | ($1.3B) | ($69.0M) |
| Settlements of net investment hedges | ($85.0M) | $71.0M | ($64.0M) |
| Proceeds from beneficial interest in securitized trade receivables | $0 | $0 | $87.0M |
| Proceeds from disposal of business and property, plant and equipment | $953.0M | $8.0M | $170.0M |
| Proceeds from sale of investments in affiliates | $100.0M | $728.0M | — |
| Payments for investments in affiliates | ($72.0M) | ($61.0M) | ($136.0M) |
| Other, net | $43.0M | ($86.0M) | $76.0M |
| Cash used for investing activities | ($5.2B) | ($1.1B) | ($1.0B) |
| Net change in short-term debt with maturities of three months or less | $1.1B | $137.0M | $138.0M |
| Proceeds from short-term debt with maturities greater than three months | $2.1B | $1.1B | $1.2B |
| Repayments of short-term debt with maturities greater than three months | ($1.3B) | ($1.1B) | ($987.0M) |
| Proceeds from long-term debt | $3.6B | $2.0B | $978.0M |
| Repayments of long-term debt | ($2.4B) | ($753.0M) | ($1.2B) |
| Debt issuance costs | ($29.0M) | ($24.0M) | — |
| Repurchases of registered or common shares | -551.0M | -1.1B | -600.0M |
| Dividends paid to registered, common or preference shareholders | ($459.0M) | ($378.0M) | ($383.0M) |
| Capital contributions (return of capital) from noncontrolling interests, net | $30.0M | $53.0M | — |
| Sale of noncontrolling interest | $206.0M | $0 | $0 |
| Acquisition of redeemable noncontrolling interest and noncontrolling interest | ($18.0M) | $0 | $0 |
| Settlement of cross currency swap | $0 | $0 | ($79.0M) |
| Other, net | ($45.0M) | ($68.0M) | $14.0M |
| Cash provided by (used for) used for financing activities | $2.2B | ($90.0M) | ($856.0M) |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $782.0M | $75.0M | $755.0M | $574.0M |
| Foreign exchange (gain) loss on net debt | ($98.0M) | ($102.0M) | ($251.0M) | ($208.0M) |
| Depreciation, depletion and amortization | $494.0M | $238.0M | $477.0M | $236.0M |
| Share-based compensation expense | $53.0M | $23.0M | $54.0M | $35.0M |
| Deferred income tax expense (benefit) | ($20.0M) | ($58.0M) | ($88.0M) | $20.0M |
| (Gain) loss on sale of investments and property, plant and equipment | ($6.0M) | — | ($155.0M) | ($148.0M) |
| Results from affiliates | ($19.0M) | ($3.0M) | ($16.0M) | ($8.0M) |
| Dividend return on investment | $47.0M | — | — | — |
| Other, net | $73.0M | $12.0M | $98.0M | $87.0M |
| Trade accounts receivable | $35.0M | ($1.0M) | ($35.0M) | ($110.0M) |
| Inventories | ($2.2B) | ($2.2B) | ($799.0M) | ($1.3B) |
| Secured advances to suppliers | ($257.0M) | ($124.0M) | ($281.0M) | ($254.0M) |
| Trade accounts payable and accrued liabilities | $344.0M | $1.0B | ($48.0M) | ($55.0M) |
| Advances on sales | ($201.0M) | ($77.0M) | ($310.0M) | ($107.0M) |
| Net unrealized (gains) losses on derivative contracts | $93.0M | $958.0M | ($125.0M) | ($120.0M) |
| Margin deposits | ($155.0M) | ($295.0M) | ($28.0M) | ($59.0M) |
| Recoverable and income taxes, net | $87.0M | $77.0M | $179.0M | $71.0M |
| Marketable securities | ($1.0M) | ($98.0M) | $34.0M | $16.0M |
| Other, net | ($142.0M) | $0 | $36.0M | ($66.0M) |
| Cash provided by (used for) operating activities | ($1.1B) | ($541.0M) | ($503.0M) | ($1.4B) |
| Payments made for capital expenditures | ($779.0M) | ($336.0M) | ($1.2B) | ($716.0M) |
| Acquisitions of businesses (net of cash acquired) | ($105.0M) | ($105.0M) | ($4.1B) | — |
| Proceeds from investments | $1.3B | $681.0M | $1.2B | $850.0M |
| Payments for investments | ($654.0M) | ($443.0M) | ($2.5B) | ($783.0M) |
| Settlements of net investment hedges | ($8.0M) | $0 | ($34.0M) | ($27.0M) |
| Proceeds from disposal of business and property, plant and equipment | $14.0M | — | $946.0M | $472.0M |
| Proceeds from sale of investments in affiliates | $0 | $0 | $100.0M | $100.0M |
| Payments for investments in affiliates | ($49.0M) | ($5.0M) | ($69.0M) | ($63.0M) |
| Other, net | $31.0M | $26.0M | $68.0M | $65.0M |
| Cash provided by (used for) investing activities | ($275.0M) | ($182.0M) | ($5.5B) | ($102.0M) |
| Net change in short-term debt with maturities of three months or less | $702.0M | ($799.0M) | $2.4B | $2.7B |
| Proceeds from short-term debt with maturities greater than three months | $1.3B | $706.0M | $1.0B | $670.0M |
| Repayments of short-term debt with maturities greater than three months | ($1.3B) | ($546.0M) | ($969.0M) | ($710.0M) |
| Proceeds from long-term debt | $1.2B | $1.2B | $3.6B | $2.3B |
| Repayments of long-term debt | ($628.0M) | ($8.0M) | ($1.4B) | ($57.0M) |
| Repurchases of registered shares | -249.0M | — | -545.0M | 0 |
| Dividends paid to registered shareholders | ($275.0M) | ($136.0M) | ($324.0M) | ($185.0M) |
| Capital contributions from (Return of capital to) noncontrolling interest | $16.0M | $16.0M | $30.0M | $30.0M |
| Sale of redeemable noncontrolling interest | $80.0M | $0 | $206.0M | $206.0M |
| Acquisition of noncontrolling interest | $0 | $0 | ($18.0M) | ($18.0M) |
| Other, net | ($13.0M) | ($25.0M) | ($14.0M) | ($5.0M) |
| Cash provided by (used for) financing activities | $832.0M | $406.0M | $4.0B | $4.9B |
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash | ($1.0M) | ($2.0M) | $3.0M | $5.0M |
| Net increase (decrease) in cash and cash equivalents, and restricted cash | ($570.0M) | ($319.0M) | ($2.0B) | $3.5B |
| Cash and cash equivalents, and restricted cash - beginning of period | $1.2B | $1.2B | $3.3B | $3.3B |
Bunge Global SA score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.